PASG
PASG
NASDAQ · Biotechnology

Passage Bio Inc

$6.38
-0.51 (-7.40%)
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Buy 11 92%
Hold 1 8%
Sell 0 0%
Price Target
Analyst Price Target +469.4% upside
Low Target $21.56
Average Target $36.33
High Target $42.60
Current Price $6.38
Current
$6.38
Target
$36.33
$21.56 $36.33 avg $42.60
Scenario Analysis
Bear Case
$21.56
237.9%
Low target
Base Case
$36.33
+469.4%
Avg target
Bull Case
$42.60
+567.7%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$20.00
-68.1% from high
52-Week Low
$5.12
+24.5% from low
Target vs 52W High
$36.33
+81.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +19.9%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.1%
GILD
Gilead Sciences Inc
Strong Buy 38 79% $362.68 +157.7%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -2.5%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -69.0%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -12.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -29.5%